top of page
Artboard 1.png
digital_primary_logo_black.png

Closing the Healthcare Gap - One Test at a Time

OUR MISSION

Vaginal infections are common.

Every year, more than 900 million women suffer from bacterial vaginosis and/or vulvovaginal candidiasis. [1,2]

But diagnosis is a mess.

66% of women misdiagnose their yeast infection. [3]

42% of women are misdiagnosed by an OB/GYN. [4]

At Shealed, we want to put an end to this.

[1] Peebles, Kathryn et al. “High Global Burden and Costs of Bacterial Vaginosis: A Systematic Review and Meta-Analysis.” Sexually transmitted diseases vol. 46,5 (2019); [2] Gonçalves, Bruna et al. “Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors.” Critical reviews in microbiology vol. 42,6 (2016); [3] Ferris, Daron G et al. “Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis.” Obstetrics and gynecology vol. 99,3 (2002); [4] Hillier, SL et al, “Diagnosis and treatment of vaginal discharge syndromes in community practice settings.” Clin Infect Dis (2020)

OUR SOLUTION

We are developing a home diagnostic test to detect active bacterial or yeast vaginal infections, delivering discreet, rapid, and accurate results.

packaging.png

Detects whether symptoms are caused by a bacterial, yeast, or mixed infection.

Helps determine whether over-the-counter treatment is appropriate.

Reduces the risk of misdiagnosis and unnecessary treatment.

Enables safe and discreet self-assessment from the comfort of home.

OUR TEAM

Lucie  Křenková

Microbiologist with experience in founding

and co-managing a family business.

Helena Ignačáková

Scientist experienced 

in diagnostics R&D and data analysis, bioinformatics enthusiast.

Brigita Benkőová

Microbiological researcher, leader of one of the
clinical diagnostic departments at SMU. 

And many other collaborators, mentors, and advisors.

CURRENT STATUS AND TIMELINE

        COMPLETED  

2024: Theoretical Concept

​​2025: Laboratory Development & Prototyping Initiation​

          IN PROGRESS  

​​​​​​​2026: Prototype Development & Preclinical Testing

​​​​​​​​2027: Analytical & Clinical Performance Studies

​​​​2028: Notified Body Evaluation

2029+: EU Market Entry & Expansion

SUPPORTED BY

Lifbee Black_edited.png
image.png

Drop us a message!

Or contact us directly at info@shealed.cz

Thanks for keeping in touch!

Asset 17.png
digital_primary_logo_black.png
bottom of page